24/7 Wall St on MSN3 小时
Dow Losing Streak Longest in 50 Years: Grab These Bargain Blue-Chip Dividend Stocks NowElectrophysiology products to treat heart rhythm disorders The heart recovery portfolio, which includes technologies to treat ...
Physicians have a new treatment option for many of the sickest pediatric patients with heart failure and cardiogenic shock. Johnson & Johnson MedTech, the global leader in heart recovery, announced ...
Baylor Scott & White The Heart Hospital-Plano in Texas cut times of cardiogenic shock diagnosis in half after implementing a quality improvement project that included nurse education and an ...
Cardiogenic shock (CS) is a life-threatening condition leading to poor prognosis and high ... As a consequence, the increased patients’ complexity and morbidity, as well as the broad etiology spectrum ...
Danvers: Johnson & Johnson MedTech, has announced that the U.S. Food and Drug Administration (FDA) has expanded the ...
Most of the change in stage of cardiogenic shock (CS) occurred within the first 24 hours of presentation, with little change thereafter, according to a study by the Cardiogenic Shock Working Group ...
Hospitals with lower risk-adjusted in-hospital mortality rates (RAMR) among patients with cardiogenic shock following acute myocardial infarction (AMI) demonstrated higher rates of revascularization ...
Boston Business Journal presents its Innovators in Healthcare honorees. Expand to read more Boston Business Journal Listen to ...
Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure, new therapies for bleeding strokes, strategies for reducing the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果